Femme et Homme
- | Pays : -
- | Organes : -
- | Spécialités : -
Extrait
The equivalence of MenC-CRM liquid to Menjugate Kit and the equivalence of MenC-CRM ROS to Menjugate Kit will be simultaneously assessed with adjustment for multiple comparisons. 1. To demonstrate the equivalence of MenC-CRM liquid to Menjugate Kit when administered to toddlers, as measured by human serum bactericidal activity (hSBA) geometric mean titers (GMTs) against N. meningitidis type C, approximately 28 days after a single vaccination. 2. To demonstrate the equivalence of MenC-CRM ROS to Menjugate Kit when administered to toddlers, as measured by human serum bactericidal activity (hSBA) geometric mean titers (GMTs) against N. meningitidis type C, approximately 28 days after a single vaccination.
Critère d'inclusion
- Prevention of meningococcal disease caused by serogroup C Neisseria meningitidis by evaluating the immunogenicity, tolerability, and safety of a liquid formulation of Novartis meningococcal C conjugate vaccine (MenC-CRM liquid) and of the lyophilized MenC-CRM vaccine produced with drug substance manufactured at Rosia, Italy, in comparison to the lyophilized MenC-CRM vaccine produced with drug substance manufactured at Emeryville, USA (Menjugate Kit)